Childhood cancers trials in Netherlands

In Netherlands 119 Also abroad 2459

119 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 12 November 2026. Ask the study team whether a trial fits you.

Phase 1/2Taking people
A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)
Where
Utrecht
Age
1 month to 17 years
People
50 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT06941272 · EU 2024-518771-66-00
Phase 2Not yet taking people in Netherlands
THRILL: Treat Hyperinflammation in child oncology study
Where
Utrecht
Age
Up to 17 years
People
76
Run by
Prinses Maxima Centrum voor Kinderoncologie B.V.
See details and how to join2025-524541-27-00 · EU 2025-524541-27-00
Phase 1/2Taking people
A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)
Where
Amsterdam, Groningen
Age
12 years and over
People
359 worldwide
Run by
Nuvalent Inc.
See details and how to joinNCT05118789 · EU 2024-511793-71-00
Phase 2Taking people
A Study to Learn More About the Study Medicine Called Inotuzumab Ozogamicin (InO) in Children (1 to <18 Years) With First Relapse ALL
Where
Utrecht
Age
1 year to 17 years
People
100 worldwide
Run by
Pfizer
See details and how to joinNCT05748171 · EU 2023-509810-13-00
Phase 3Taking people
CHIP-AML22 Master protocol: Protocol for the treatment of children and adolescents with Acute Myeloid Leukemia (AML)
Where
Utrecht
Age
Up to 64 years
People
675 worldwide
Run by
Prinses Maxima Centrum voor Kinderoncologie B.V.
See details and how to join2023-504999-25-00 · EU 2023-504999-25-00
Phase 2Enrolling by invitation
Long-Term Follow-Up Study After Gene-Modified Cell Treatment in Kite Studies
Where
Amsterdam, Groningen, Nijmegen, Rotterdam, Utrecht
People
1,500 worldwide
Run by
Kite, A Gilead Company
See details and how to joinNCT05041309 · EU 2023-507041-28-00
No phaseNot yet taking people in Netherlands
Effectiveness of a Visual Telerehabilitation Program on Visual Perception in Children, Adolescents and Young Adults With Hemianopsia Consecutive to a Brain Tumour
Where
Utrecht
Age
10 years to 40 years
People
120 worldwide
Run by
Institut National de la Santé Et de la Recherche Médicale, France
See details and how to joinNCT07558395
Phase 3Taking people
An international trial for children with atypical teratoid/rhabdoid tumours (ATRT)
Where
Groningen, Utrecht
Age
Up to 17 years
People
301 worldwide
Run by
GPOH gGmbH
See details and how to join2022-501456-28-00 · EU 2022-501456-28-00
Phase 3Taking people
Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET
Where
Rotterdam, Utrecht
Age
12 years to 100 years
People
240 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT06784752 · EU 2024-518325-15-00
Phase 1Taking people
Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
Where
Groningen, Leiden
Age
12 years to 85 years
People
411 worldwide
Run by
Inhibrx Biosciences, Inc
See details and how to joinNCT03715933 · EU 2023-508139-29-00
No phaseTaking people
Targeted Pediatric High-Grade Glioma Therapy
Where
Utrecht
Age
12 months to 39 years
People
350 worldwide
Run by
Nationwide Children's Hospital
See details and how to joinNCT05839379
Phase 3Taking people
SIOP RANDOMET 2017
Where
Utrecht
Age
Up to 17 years
People
409 worldwide
Run by
GPOH gGmbH
See details and how to join2023-508926-91-00 · EU 2023-508926-91-00
Phase 3Taking people
SIOP-HRMB: An international prospective trial on clinically high-risk medulloblastoma (HR-MB) in patients older than 3 years.
Where
Groningen, Utrecht
Age
Up to 64 years
People
311 worldwide
Run by
The University Of Birmingham
See details and how to join2024-510578-25-00 · EU 2024-510578-25-00
Phase 2/3Taking people
Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia
Where
Utrecht
Age
1 month to 18 years
People
1,800 worldwide
Run by
St. Anna Kinderkrebsforschung
See details and how to joinNCT01949129 · EU 2024-512657-24-00
Phase 2Taking people
Study of Olutasidenib and Temozolomide in HGG
Where
Utrecht
Age
12 years to 39 years
People
60 worldwide
Run by
Rigel Pharmaceuticals
See details and how to joinNCT06161974
Phase 2Taking people
Study to evaluate the safety and efficacy of asciminib in pediatric participants with chronic myeloid leukemia.
Where
Utrecht
Age
Up to 17 years
People
16 worldwide
Run by
Novartis Pharma AG
See details and how to join2025-522138-29-00 · EU 2025-522138-29-00
Phase 1Taking people
Long-Term Follow-Up (LTFU) of Participants Treated with Adoptive Cell Therapies
Where
Amsterdam
People
7 worldwide
Run by
USWM Ct LLC
See details and how to join2024-513033-21-00 · EU 2024-513033-21-00
No phaseTaking people
Cerebellar Mutism Syndrome Study
Where
Groningen, Nijmegen, Utrecht
Age
Up to 18 years
People
2,000 worldwide
Run by
Copenhagen University Hospital, Rigshospitalet
See details and how to joinNCT02300766
Phase 3Taking people
A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia
Where
Utrecht
Age
0 years to 45 years
People
6,430 worldwide
Run by
Mats Heyman
See details and how to joinNCT04307576 · EU 2022-501050-11-01
Phase 1Enrolling by invitation
Adoptive Cell Therapy Long-term Follow-up (LTFU) Study
Where
Amsterdam
People
250 worldwide
Run by
USWM CT, LLC
See details and how to joinNCT03391778
Phase 2Taking people
A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
Where
Leiden, Utrecht
Age
1 year to 39 years
People
105 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT05999994
Phase 2Taking people
Revumenib Treatment in Combination with FLA Chemotherapy in Paediatric Refractory/Relapsed KMT2A-r, NUP98-r or NPM1-mut Acute Myeloid Leukemia (AML)
Where
Utrecht
Age
Up to 64 years
People
31 worldwide
Run by
Pediatric Research International GmbH
See details and how to join2025-521390-14-00 · EU 2025-521390-14-00
Phase 2Taking people
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Where
Rotterdam
Age
8 years and over
People
254 worldwide
Run by
Fore Biotherapeutics
See details and how to joinNCT05503797 · EU 2024-513578-23-00
No phaseTaking people
Novel Ga68-PSMA PET/CT-tracer to Differentiate Between Radiation Necrosis and Tumor Progression in Brain Metastases
Where
Amsterdam
People
100
Run by
The Netherlands Cancer Institute
See details and how to joinNCT07511933
Phase 3Taking people
Fight Osteosarcoma Through European Research evolving study platform from diagnosis to relapse (FOSTER evolving study platform)
Where
Groningen, Leiden, Nijmegen, Utrecht
People
508 worldwide
Run by
Institut Gustave Roussy
See details and how to join2023-505575-69-01 · EU 2023-505575-69-01